tiprankstipranks
Trending News
More News >
Amplifon S.p.A. (IT:AMP)
:AMP
Advertisement

Amplifon S.p.A. (AMP) AI Stock Analysis

Compare
33 Followers

Top Page

IT:AMP

Amplifon S.p.A.

(LSE:AMP)

Rating:55Neutral
Price Target:
€16.00
▲(5.96% Upside)
Amplifon S.p.A. faces significant challenges with declining revenue growth and increased leverage, impacting its financial performance. The technical analysis indicates a bearish trend, and the valuation suggests the stock is relatively expensive. These factors contribute to a moderate overall stock score.

Amplifon S.p.A. (AMP) vs. iShares MSCI Italy ETF (EWI)

Amplifon S.p.A. Business Overview & Revenue Model

Company DescriptionAmplifon S.p.A. is a global leader in the distribution of hearing aids and related services, dedicated to improving the quality of life for individuals with hearing loss. Founded in 1950 and headquartered in Milan, Italy, the company operates in over 20 countries, providing innovative hearing solutions, audiological services, and personalized customer care. Amplifon offers a wide range of products, including hearing aids from leading manufacturers and its own branded devices, as well as accessories and assistive listening devices.
How the Company Makes MoneyAmplifon generates revenue primarily through the sale of hearing aids and audiological services. The company's key revenue streams include direct sales of hearing aids to customers through its retail network, as well as online sales. Additionally, Amplifon earns income from after-sales services, such as maintenance and repairs, which are essential for customer satisfaction and retention. The company also benefits from partnerships with various manufacturers, which allows it to offer a diverse product range and capitalize on the latest technological advancements in hearing solutions. Furthermore, Amplifon engages in B2B partnerships with healthcare providers and insurance companies, facilitating access to its products and services for a broader audience, thereby contributing to its overall earnings.

Amplifon S.p.A. Financial Statement Overview

Summary
Amplifon S.p.A. demonstrates stable profitability and cash flow management, but faces challenges with declining revenue growth and increased leverage. The company needs to address these issues to maintain financial health and shareholder value.
Income Statement
65
Positive
Amplifon S.p.A. shows a stable gross profit margin around 56%, indicating efficient cost management. However, the net profit margin has decreased to 5.2% in the TTM, reflecting reduced profitability. The revenue growth rate is negative in the TTM, suggesting a decline in sales performance. EBIT and EBITDA margins have also slightly decreased, indicating potential operational challenges.
Balance Sheet
60
Neutral
The company's debt-to-equity ratio has increased to 1.81 in the TTM, indicating higher leverage and potential financial risk. Return on equity has decreased to 11.4%, suggesting reduced profitability for shareholders. The equity ratio remains stable, reflecting a balanced asset structure.
Cash Flow
70
Positive
Free cash flow growth is positive at 2.6% in the TTM, showing improved cash generation. The operating cash flow to net income ratio is below 1, indicating potential cash flow constraints. However, the free cash flow to net income ratio is strong at 0.72, suggesting efficient cash utilization.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.42B2.41B2.26B2.12B1.95B1.56B
Gross Profit1.36B1.36B548.45M1.18B1.11B863.16M
EBITDA549.97M557.25M522.01M513.82M468.72M361.67M
Net Income126.08M145.37M155.14M178.53M157.78M101.00M
Balance Sheet
Total Assets3.86B3.99B3.69B3.58B3.52B3.23B
Cash, Cash Equivalents and Short-Term Investments242.69M288.85M194.00M229.54M318.44M554.02M
Total Debt1.83B1.72B1.52B1.50B1.61B1.56B
Total Liabilities2.85B2.84B2.59B2.54B2.59B2.43B
Stockholders Equity1.01B1.15B1.10B1.04B925.18M800.88M
Cash Flow
Free Cash Flow318.25M366.19M271.89M342.99M348.97M330.63M
Operating Cash Flow442.77M449.35M413.54M458.62M462.37M391.47M
Investing Cash Flow-257.99M-335.10M-261.48M-193.78M-533.61M-134.28M
Financing Cash Flow-92.17M-18.85M-135.06M-353.80M-208.64M151.52M

Amplifon S.p.A. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price15.10
Price Trends
50DMA
17.52
Negative
100DMA
18.33
Negative
200DMA
20.76
Negative
Market Momentum
MACD
-0.55
Negative
RSI
34.90
Neutral
STOCH
7.29
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AMP, the sentiment is Negative. The current price of 15.1 is below the 20-day moving average (MA) of 15.30, below the 50-day MA of 17.52, and below the 200-day MA of 20.76, indicating a bearish trend. The MACD of -0.55 indicates Negative momentum. The RSI at 34.90 is Neutral, neither overbought nor oversold. The STOCH value of 7.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:AMP.

Amplifon S.p.A. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
€497.73M4.80
4.84%16.92%
73
Outperform
€457.91M27.81
2.11%17.78%63.72%
55
Neutral
€3.41B27.1411.68%1.92%3.83%-21.96%
51
Neutral
$7.91B-0.36-41.71%2.23%23.45%-1.86%
€51.35M19.887.16%
€434.54M19.606.75%
€43.49M7.76
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IT:AMP
Amplifon S.p.A.
15.10
-12.48
-45.26%
IT:PHN
PharmaNutra SpA
47.30
-6.50
-12.08%
DE:6I50
Health Italia SpA
277.00
206.44
292.57%
DE:GHC
Garofalo Health Care S.P.A.
4.84
-0.23
-4.54%
IT:GPI
GPI SpA
17.56
6.41
57.49%
IT:SVS
Svas Biosana S.p.A.
8.14
0.67
8.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025